Alyeska Investment Group, L.P. Amneal Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $823,553 - $1.83 Million	-127,881 Reduced 32.35%	267,475 $0
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $1.82 Million - $2.27 Million	153,112 Added 63.21%	395,356 $0
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $5.02 Million - $8.23 Million	-383,178 Reduced 61.27%	242,244 $3.28 Million
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $7.35 Million - $10.9 Million	447,982 Added 252.47%	625,422 $13.9 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $2.48 Million - $3.58 Million	177,440 New	177,440 $2.91 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.